20 results on '"Lipinski F"'
Search Results
2. Sites de récidives du cancer du canal anal après chimioradiothérapie avec modulation d’intensité : analyse rétrospective multicentrique
- Author
-
Amestoy, F., primary, Antoine, M., additional, Henriques, B., additional, Lipinski, F., additional, Genebes, C., additional, Blouet, A., additional, Celerier, D., additional, Regnault de la Mothe, P., additional, Debelleix, C., additional, Petit, A., additional, Laharie-Mineur, H., additional, Bonichon-Lamichhane, N., additional, and Vendrely, V., additional
- Published
- 2018
- Full Text
- View/download PDF
3. Place de la radiothérapie de conformation dans la pratique quotidienne: enquête nationale auprès des membres de la SFRO
- Author
-
Lagrange, J.L. and Lipinski, F.
- Published
- 2001
- Full Text
- View/download PDF
4. Herausforderungen in der Diagnose der Autosomal Rezessiven Bestrophinopathie: Neuartige BEST1-Mutationen und zusätzliche Fallberichte
- Author
-
Book, B, Stöhr, H, Weber, B, von Wnuck-Lipinski, F, and Spital, S
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Einleitung: Die in 2008 erstmals beschriebene autosomal rezessive Bestrophinopathie (ARB) zeichnet sich aufgrund unterschiedlicher homozygoter oder komplex heterozygoter Mutationen im BEST1-Gen durch ein breites phänotypisches Spektrum aus. Methoden: Wir erhoben folgende Untersuchungen bei[zum vollständigen Text gelangen Sie über die oben angegebene URL], 179. Versammlung des Vereins Rheinisch-Westfälischer Augenärzte
- Published
- 2017
- Full Text
- View/download PDF
5. État des lieux de la radiothérapie en conditions stéréotaxiques vertébrale en France en 2016
- Author
-
Pougnet, I., primary, Jaegle, E., additional, Garcia, R., additional, Tessier, F., additional, Faivre, J.C., additional, Louvel, G., additional, Gross, E., additional, Gonzague, L., additional, Benchalal, M., additional, Ducteil, A., additional, Supiot, S., additional, Autret, D., additional, Clavier, J.B., additional, Mirabel, X., additional, Bellière, A., additional, Wdowczyk, D., additional, Heymann, S., additional, Barillot, I., additional, de La Lande, B., additional, Passerat, V., additional, Sunyach, M.P., additional, Lipinski, F., additional, Thibouw, D., additional, Guichard, F., additional, Chauvet, B., additional, Thariat, J., additional, and Arnaud, A., additional
- Published
- 2017
- Full Text
- View/download PDF
6. Post radiation severe xerostomia relieved by pilocarpine: A prospective French cooperative study
- Author
-
Horlot, J.C., primary, Lipinski, F., additional, Schraub, S., additional, Maylin, C., additional, Bensadoun, R.J., additional, Ardiet, J.M., additional, Bolla, M., additional, Coscas, Y., additional, Baillet, F., additional, Coche-dequéant, B., additional, Urbajtel, M., additional, Montbarbon, X., additional, Bouedin, S., additional, Wibault, P., additional, Pene, F., additional, Alfonsi, M., additional, Calais, G., additional, Desprez, P., additional, Lapeyre, M., additional, Vinke, J., additional, Labart, M., additional, and Savary, J., additional
- Published
- 1997
- Full Text
- View/download PDF
7. 151Can pilocarpine hydrochloride relieve xerostomia regardless of the destruction of major salivary glands? A prospective French cooperative study
- Author
-
Horiot, J.C., primary, Lipinski, F., additional, Schraub, S., additional, Maylin, C., additional, Bensadoun, R.J., additional, Gérard, J.P., additional, Bolla, M., additional, Coscas, Y., additional, Baillet, F., additional, Coche-Dequéant, B., additional, Urbajtel, M., additional, Montbarbon, X., additional, Bourdin, S., additional, Wibault, P., additional, Pene, F., additional, Alfonsi, M., additional, Calais, G., additional, Desprez, P., additional, Favre, A., additional, Lapeyre, M., additional, Vinke, J., additional, Labart, M., additional, and Savary, J., additional
- Published
- 1996
- Full Text
- View/download PDF
8. Changes in testicular fluid production and plasma hormones in the adult rat after testicular 60Co irradiation
- Author
-
Laporte, P., Viguier-Martinez, Marie-Claude, Zongo, D., Le Floch, O., Lipinski, F., and Revues Inra, Import
- Subjects
[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition ,[SDV.BDD] Life Sciences [q-bio]/Development Biology ,[SDV.BDLR] Life Sciences [q-bio]/Reproductive Biology - Published
- 1985
9. [Sympathetic paraganglioma. Scintigraphic detection using a new labeled molecule, meta-iodobenzylguanidine]
- Author
-
Jl, Baulieu, Denis Guilloteau, Fetissof F, Caron J, Lecomte P, Jl, Guilmot, Lipinski F, Baulieu F, Itti R, and Pourcelot L
- Subjects
Adult ,Ganglia, Sympathetic ,Iodobenzenes ,Adrenal Gland Neoplasms ,Bone Neoplasms ,Pheochromocytoma ,Bone and Bones ,Iodine Radioisotopes ,Paraganglioma ,3-Iodobenzylguanidine ,Catecholamines ,Abdominal Neoplasms ,Sympatholytics ,Humans ,Female ,Radionuclide Imaging - Abstract
Two cases of sympathetic paraganglioma are reported: one, benign, in a 20-years old woman with arterial hypertension and attacks of excessive sweating; the other, malignant and with bone metastases, in a 44-years old woman. Both were diagnosed by scintigraphy, using meta-iodobenzylguanidine as radionuclide. This new radiopharmaceutic agent has recently been introduced for the detection of phaeochromocytomas, but it seems to be a general tissue marker of catecholamine uptake and storage. Its use as a therapeutic compound may also be envisaged.
- Published
- 1984
10. Changes in testicular fluid production and plasma hormones in the adult rat after testicular 60Co irradiation
- Author
-
LAPORTE, P., primary, VIGUIER-MARTINEZ, Marie-Claude, additional, ZONGO, D., additional, LE FLOCH, O., additional, and LIPINSKI, F., additional
- Published
- 1985
- Full Text
- View/download PDF
11. Breast cancer care compared with clinical Guidelines: an observational study in France
- Author
-
Daban Alain, Tunon-de-Lara Christine, Bellera Carine, Mathoulin-Pélissier Simone, Lebeau Marie, Lipinski Francis, Jaubert Dominique, Ingrand Pierre, and Migeot Virginie
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels. Methods Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals). The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression). Results 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05). Conclusion This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements.
- Published
- 2011
- Full Text
- View/download PDF
12. Michele Cometa
- Author
-
Valeria Cammarata, PURGAR, K, SHAW, M, PAPPAS, N, GIAKOUMIS, K, VERSTEGEN, I, KUPLEN, M, PINOTTI, A, HAUG, S, VON MÜLLER, J, RAMLJAK PURGAR, M, GNAMUŠ, N, STRAYER, J, MALAVASI, L, HAAR, R, HOEZL I, MARIE, R, ROZZONI, C, PAIĆ, Z, LECHTE, J, GORNYKH, A, GENOSKO, G, ZAREMBA, L, STEFANOVIC, P, GRUIĆ PARAĆ, A, ARIELLI, E, VUGER, D, LIPINSKI, F, BOIDY, M, RABBITO, A, MOLONEY, D, CONTE, P, ALLOA, E, KULVICKI, J, DEGIRMENCI, K, VÄGNES, Ø, PICHLER, W, GRØNSTAD, A, HALAWA-SARHOLZ, M, UGENTI, E, DAVID, G., MÄCKLIN, H, MENGONI, A, LOUVEL, L, LANER, I, PRÜCHOVÁ HRÜZOVÁ, A, RAMPLEY, M, CAMBRE, C, IONESCU, V, DRIESSCHE, M, DE MEY, L, RUF, O, FELL, E, VARGIU, L, WILDE, L R A, FINKE, M, HADJINICOLAOU, Y, FÖRSTER, Y, VILLINGER, R, LEŚNIAK, A, and Cammarata, Valeria
- Subjects
Settore L-FIL-LET/14 - Critica Letteraria E Letterature Comparate ,MIchele Cometa, Visual Culture, Ekphrasis, Phototexts - Abstract
This essay is about Michele Cometa, essayist, literary and aesthetic critic and one of the founders of Italian Visual Culture ,both as a cultural approach and as an academic discipline (or, rather, un-discipline). He is responsible for the reception of W.J.T. Mitchell in Italy, having edited the first translations of his works (see, Pictorial Turn. Essays on Visual Culture, 2008, new edition 2017). He also organized the first meeting entirely devoted to the discipline in 2007, hosting the encounter between Mitchell’s Pictorial turn and Belting’s Iconic Turn and the different approaches they gave origin to in Italy.
- Published
- 2021
13. [Spinal stereotactic body radiotherapy: French assessment in 2016].
- Author
-
Pougnet I, Jaegle E, Garcia R, Tessier F, Faivre JC, Louvel G, Gross E, Gonzague L, Benchalal M, Ducteil A, Supiot S, Autret D, Clavier JB, Mirabel X, Bellière A, Wdowczyk D, Heymann S, Barillot I, de La Lande B, Passerat V, Sunyach MP, Lipinski F, Thibouw D, Guichard F, Chauvet B, Thariat J, and Arnaud A
- Subjects
- France, Health Care Surveys, Humans, Practice Patterns, Physicians', Radiosurgery, Spinal Neoplasms radiotherapy
- Abstract
Purpose: Stereotactic body radiotherapy to vertebral column remains uncommon practice and only relevant in selected group of patients. The main objective of the study was to describe the current state of medical practices of stereotactic body radiotherapy to vertebral column in France in 2016 and to assess the diversity of practices to identify areas for improvement and establish a common database set for this technique., Materials and Methods: A questionnaire was written with contribution of a medical physicist, a radiation oncologist, an information technologist and a radiotherapy resident. The questionnaire was distributed online to a radiation oncologists and a medical physicists partner of selected French radiotherapy specialized centres that provide stereotactic body radiotherapy to vertebral metastasis from April to June 2016. The questionnaire surveyed the following topics: patients' selection, simulation, targeted volume and organs at risk delineation, prescription, dosimetric implementation and image guidance., Results: A total of 31 centres were surveyed. Seventy eight per cent of centres (n=21) completed the questionnaire. The "ideal" patient for spine stereotactic radiotherapy according to these institutions has a good performance status, a long life expectancy, controlled primary tumour with oligometastatic spread. The most prescribed protocol was 30Gy in three fractions. For clinical target volume delineation, about two thirds of centres used the International Spine Radiosurgery Consortium (ISRC) recommendations (Noël G et al.,2006)., Conclusion: This study identified some consistency of practices in some aspects despite the lack of consensus guidelines. Nevertheless, further studies are needed to establish consensus of planning and treatment., (Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
14. [White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].
- Author
-
Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Chauvet B, Mahé MA, Maingon P, Mazeron JJ, Mornex F, Azria D, Barillot I, Chauvet B, Denis F, Lartigau É, Lipinski F, Maingon P, Mornex F, Ardiet JM, Bibault JE, Caudrelier V, Diaz O, de Crevoisier R, Dubray B, Estivalet S, Faivre JC, Fenoglietto P, Fumagalli I, Ferlay J, Giraud P, Hennequin C, Henoch H, Khodri M, Llacer C, Lagrange JL, Lorchel F, Mahé MA, Meyrieux C, de Martel C, Noël G, Oozeer R, Peiffert D, Pointreau Y, Pourel N, Pradier O, Rocher F, Thureau S, Eschwège F, Martin P, and Parmentier G
- Subjects
- Clinical Trials as Topic, Diffusion of Innovation, Financing, Organized legislation & jurisprudence, France, Government Agencies, Health Services Accessibility legislation & jurisprudence, Health Services Accessibility trends, Humans, Informed Consent legislation & jurisprudence, Interdisciplinary Communication, Neoplasms radiotherapy, Patient Education as Topic standards, Quality Assurance, Health Care, Quality Improvement, Radiation Injuries etiology, Radiation Injuries prevention & control, Radiation Oncology education, Radiation Oncology organization & administration, Radiation Oncology trends, Radiosurgery, Radiotherapy adverse effects, Radiotherapy economics, Radiotherapy ethics, Radiotherapy instrumentation, Radiotherapy methods, Radiotherapy trends, Radiotherapy Dosage, Research, Risk Management, Societies, Medical, Societies, Scientific, Socioeconomic Factors, Staff Development, Technology, High-Cost, Translational Research, Biomedical, Workforce, Radiotherapy standards
- Published
- 2013
- Full Text
- View/download PDF
15. Breast cancer care compared with clinical Guidelines: an observational study in France.
- Author
-
Lebeau M, Mathoulin-Pélissier S, Bellera C, Tunon-de-Lara C, Daban A, Lipinski F, Jaubert D, Ingrand P, and Migeot V
- Subjects
- Adult, Aged, Aged, 80 and over, Breast Neoplasms surgery, Female, France, Guideline Adherence classification, Humans, Logistic Models, Middle Aged, Multivariate Analysis, Neoplasm Staging, Odds Ratio, Practice Patterns, Physicians' standards, Social Class, Surveys and Questionnaires, Young Adult, Breast Neoplasms therapy, Decision Making, Guideline Adherence standards, Patient Compliance psychology, Patient Compliance statistics & numerical data, Quality of Health Care standards
- Abstract
Background: Great variability in breast cancer (BC) treatment practices according to patient, tumour or organisation of care characteristics has been reported but the relation between these factors is not well known. In two French regions, we measured compliance with Clinical Practice Guidelines for non-metastatic BC care management and identified factors associated with non-compliance at clinical and organisational levels., Methods: Eligible patients had invasive unilateral BC without distant metastases and at least two contacts with one of the two regional healthcare systems (2003-2004) in the first year after diagnosis. Medical data were collected from patient medical records in all public and private hospitals (99 hospitals).The care process was defined by 20 criteria: clinical decisions for treatment and therapeutic procedures. Each criterion was classified according to level of compliance ("Compliant", "Justifiable" and "Not Compliant") and factors of non-compliance were identified (mixed effect logistic regression)., Results: 926 women were included. Non-compliance with clinical decisions for treatment was associated with older patient age (OR 2.1; 95%CI: 1.3-3.6) and region (OR 3.0; 95%CI: 1.2-7.4). Non-compliance with clinical decisions for radiotherapy was associated with lymph node involvement or the presence of peritumoural vascular invasion (OR 1.5; 95%CI: 1.01-2.3) and non-compliance with overall treatment (clinical decisions for treatment + therapeutic procedures) was associated with the presence of positive lymph nodes (OR 2.0; 95%CI: 1.2-3.3), grade III versus grade I (OR 2.9; 95%CI: 1.4-6.2), and one region of care versus another (OR 3.5; 95%CI: 1.7-7.1). Finally, heterogeneity of compliance in overall treatment sequence was identified between local cancer units (p < 0.05)., Conclusion: This study provides interesting insights into factors of non-compliance in non-metastatic BC management and could lead to quality care improvements.
- Published
- 2011
- Full Text
- View/download PDF
16. [French radiotherapy database: results of a survey of French radiation oncology centers in 2007].
- Author
-
Chauvet B, Bolla M, Alies-Patin A, Bara C, Bourguignon M, Chantôme G, Eschwège F, Estivalet S, Fau P, Fournie E, Lipinski F, Mazeron JJ, Mornex F, Pointreau Y, and Weissmann H
- Subjects
- Databases as Topic standards, France, Health Surveys, Hospitals, Private standards, Hospitals, Private statistics & numerical data, Hospitals, Public standards, Hospitals, Public statistics & numerical data, Humans, Radiation Oncology standards, Radiotherapy standards, Radiation Oncology statistics & numerical data, Radiotherapy statistics & numerical data
- Abstract
For the second year, the French Radiotherapy Database presents information from French radiation oncology centers. Among 179 centers, 159 have participated (90 %). The number of accelerators increased from 371 to 384 between 2006 and 2007, 11 % of these machines are more than 15 years old. On average, centers are open 50 hours per week for treatment and 9.5 % more for maintenance. The lack of dedicated CT remains a difficulty: 158 from 159 centers have an access to a CT, but only 50 % have a dedicated scanner. There is no progress compared to 2006. The proportion of centers having a MU double calculation system has increased from 51 to 58 %. Two thirds of centers do not implement in vivo dosimetry. The activity is stable around 190 000 treatments per year. Three-dimension conformal radiotherapy is used for more than half of treatments in 77.2 % of private centers and 50 % of public hospitals. Intensity modulated radiotherapy remains rarely used. The number of radiation oncologists and technologists remains stable. The number of radiophysicists has increased from 7.6 %. Despite some progress, the difficulties of this speciality persist in France and are equally distributed across all regions, and between private and public centers. In 2009, the French Society for Radiation Oncology and the associated partners will continue this survey, which interest is recognized by both professionals and health administrations.
- Published
- 2009
- Full Text
- View/download PDF
17. [The place of conformal radiotherapy in routine practice: national survey of SFRO members].
- Author
-
Lagrange JL and Lipinski F
- Subjects
- Carcinoma, Non-Small-Cell Lung radiotherapy, Central Nervous System Neoplasms radiotherapy, Female, France, Head and Neck Neoplasms radiotherapy, Health Care Surveys, Humans, Lung Neoplasms radiotherapy, Male, Prostatic Neoplasms radiotherapy, Retrospective Studies, Tomography, X-Ray Computed, Neoplasms radiotherapy, Practice Patterns, Physicians' statistics & numerical data, Radiotherapy, Conformal statistics & numerical data
- Abstract
National French investigation of the using of conformal radiotherapy in routine work, has been made in 2001, in 180 radiotherapeutic centers. Eighty responses have been obtained and analyzed. Conformal radiotherapy is used in 88% and virtual simulation in 60% of these centers. There is a heterogeneity in the equipment of these institutions, most of them have one or two machines. The accelerator equipment differs, and the disponibility of multileaf collimators and electronic portal imaging is limited. Actually only eleven centers have IMRT, eight have projects to install. Only six centers have CT-scans, used mainly for simulation. In 75% of centers, conformal radiotherapy have been used in the treatment of CNS-tumors, head and neck cancers, prostate, and non-small cell lung carcinoma. If there are more equipment and human facilities to use conformal radiotherapy, this treatment can be proposed to patients with breast cancer, rectal and gynecological tumors. According 90% of responses, all prostatic cancers need conformal radiotherapy. The analysis of routine use of conformal radiotherapy in France shows an important heterogeneity but it seems that there is an agreement with objectives of this treatment.
- Published
- 2001
18. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
- Author
-
Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, Bolla M, Coscas Y, Baillet F, Coche-Dequéant B, Urbajtel M, Montbarbon X, Bourdin S, Wibault M, Alfonsi M, Calais G, Desprez P, Pene F, Lapeyre M, Vinke J, and Maral J
- Subjects
- Administration, Oral, Adult, Aged, Aged, 80 and over, Female, Head and Neck Neoplasms radiotherapy, Humans, Male, Middle Aged, Muscarinic Agonists administration & dosage, Pilocarpine administration & dosage, Prospective Studies, Quality of Life, Radiation Injuries etiology, Radiotherapy adverse effects, Saliva metabolism, Salivary Glands drug effects, Salivary Glands metabolism, Severity of Illness Index, Xerostomia etiology, Muscarinic Agonists therapeutic use, Pilocarpine therapeutic use, Radiation Injuries drug therapy, Salivary Glands radiation effects, Xerostomia drug therapy
- Abstract
Background and Purpose: The aim of the study was: (1) to confirm the action of pilocarpine hydrochloride (Salagen) against xerostomia: (2) to correlate the response to dose/volume radiotherapy parameters., Materials and Methods: From June 1995 to February 1996, 156 patients with severe radiation induced xerostomia received pilocarpine hydrochloride orally. IS mg per day with a 5 mg optional increase at S weeks up to a daily dose of 25 mg beyond 9 weeks., Results: One hundred and forty five patients are fully evaluable. Treatment compliance was 75%. Thirty eight patients (26%) stopped treatment before week 12 for acute intolerance (sweating, nausea, vomiting) or no response. No severe complication occurred. Ninety ses en patients (67%) reported a significant relief of symptoms of xerostomia at 12 weeks. Within 12 weeks, the size of the subgroup ith normal food intake almost doubled (13-24 patients) while the size of the subgroup with (nearly) impossible solid food ingestion decreased by 38% (47 vs. 29 patients). The impact on quality of life was considered important or very important by 77% of the responders., Conclusions: No difference was found according to dose/volume radiotherapy parameters suggesting that oral pilocarpine hydrochloride: (1) acts primarily by stimulating minor salivary glands: (2) can be of benefit to patients suffering of severe xerostomia regardless of radiotherapy dose/volume parameters: (3) all responders are identified at 12 weeks.
- Published
- 2000
- Full Text
- View/download PDF
19. [Sympathetic paraganglioma. Scintigraphic detection using a new labeled molecule, meta-iodobenzylguanidine].
- Author
-
Baulieu JL, Guilloteau D, Fetissof F, Caron J, Lecomte P, Guilmot JL, Lipinski F, Baulieu F, Itti R, and Pourcelot L
- Subjects
- 3-Iodobenzylguanidine, Abdominal Neoplasms diagnostic imaging, Adrenal Gland Neoplasms diagnostic imaging, Adult, Bone Neoplasms diagnostic imaging, Bone Neoplasms secondary, Bone and Bones diagnostic imaging, Catecholamines metabolism, Female, Ganglia, Sympathetic, Humans, Iodine Radioisotopes, Paraganglioma secondary, Pheochromocytoma diagnostic imaging, Radionuclide Imaging, Iodobenzenes, Paraganglioma diagnostic imaging, Sympatholytics
- Abstract
Two cases of sympathetic paraganglioma are reported: one, benign, in a 20-years old woman with arterial hypertension and attacks of excessive sweating; the other, malignant and with bone metastases, in a 44-years old woman. Both were diagnosed by scintigraphy, using meta-iodobenzylguanidine as radionuclide. This new radiopharmaceutic agent has recently been introduced for the detection of phaeochromocytomas, but it seems to be a general tissue marker of catecholamine uptake and storage. Its use as a therapeutic compound may also be envisaged.
- Published
- 1984
20. [Cis-platinum and polychemotherapy in the initial treatment of extensive carcinoma of the upper aerodigestive tract (45 cases)].
- Author
-
Garand G, Calais G, Dauphin D, Lociciro C, Le Floch O, and Lipinski F
- Subjects
- Aged, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Oropharynx pathology, Antineoplastic Agents administration & dosage, Carcinoma, Squamous Cell drug therapy, Cisplatin administration & dosage, Head and Neck Neoplasms drug therapy, Pharyngeal Neoplasms drug therapy
- Published
- 1982
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.